Wang S, Fan D, Yao Q, Sun X, et al. The cost-utility and budget impact analyses of Tirzepatide versus once-weekly Semaglutide as add-on therapy to metformin in patients with type 2 diabetes mellitus in China. Diabetes Obes Metab 2025 Jul 2. doi: 10.1111/dom.16580.
PMID: 40600464